NORGES BANK - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2021$18,936,000
+27.4%
586,420
+20.7%
0.00%
+33.3%
Q2 2021$14,861,000
-11.3%
485,986
-11.7%
0.00%
-25.0%
Q1 2021$16,753,000
+15.8%
550,193
-24.8%
0.00%
+33.3%
Q4 2020$14,461,000
+68.7%
731,258
+11.2%
0.00%
+50.0%
Q3 2020$8,572,000
+4.3%
657,358
-9.3%
0.00%0.0%
Q2 2020$8,217,000
-34.7%
724,583
-17.6%
0.00%
-50.0%
Q1 2020$12,585,000
-48.3%
879,477
-1.7%
0.00%
-42.9%
Q4 2019$24,362,000
-4.9%
894,6890.0%0.01%
-12.5%
Q3 2019$25,615,000
-11.1%
894,689
-13.7%
0.01%
-11.1%
Q2 2019$28,804,000
-25.4%
1,036,869
-10.8%
0.01%
-25.0%
Q1 2019$38,606,000
+14.2%
1,162,8120.0%0.01%
-7.7%
Q4 2018$33,803,000
-36.8%
1,162,8120.0%0.01%
-23.5%
Q3 2018$53,490,000
+20.7%
1,162,812
-1.9%
0.02%
+13.3%
Q2 2018$44,309,000
+21.7%
1,185,690
-3.8%
0.02%
+15.4%
Q1 2018$36,416,000
-19.1%
1,232,329
-6.0%
0.01%
-18.8%
Q4 2017$45,007,000
-11.6%
1,310,443
-6.9%
0.02%
-15.8%
Q3 2017$50,932,000
+49.7%
1,407,732
+6.9%
0.02%
+35.7%
Q2 2017$34,018,000
+40.2%
1,316,479
+4.2%
0.01%
+40.0%
Q1 2017$24,256,000
+69.4%
1,263,347
+47.1%
0.01%
+66.7%
Q4 2016$14,319,000
-3.5%
858,972
+13.8%
0.01%
-14.3%
Q3 2016$14,841,000
-27.4%
755,045
+13.0%
0.01%
-30.0%
Q2 2016$20,443,000
-1.4%
668,070
+20.6%
0.01%0.0%
Q1 2016$20,729,000
-21.0%
553,804
-8.9%
0.01%
-23.1%
Q4 2015$26,236,000
+15.2%
607,8720.0%0.01%
+8.3%
Q3 2015$22,783,000
+35.9%
607,872
+23.2%
0.01%
+50.0%
Q2 2015$16,768,000
-30.6%
493,323
-27.8%
0.01%
-33.3%
Q1 2015$24,177,000
-11.6%
682,953
-14.9%
0.01%
-14.3%
Q4 2014$27,335,000
-8.1%
802,565
+4.0%
0.01%
-12.5%
Q3 2014$29,758,000
-41.5%
771,536
-41.0%
0.02%
+14.3%
Q2 2014$50,854,000
+127.7%
1,306,632
+100.0%
0.01%
+7.7%
Q1 2014$22,337,000
+63.0%
653,3160.0%0.01%
+62.5%
Q4 2013$13,706,000
-1.8%
653,316
+10.0%
0.01%0.0%
Q3 2013$13,953,000
+26.3%
593,767
+44.4%
0.01%
+14.3%
Q2 2013$11,048,000
+61.3%
411,179
+52.4%
0.01%
+75.0%
Q1 2013$6,851,000
-16.3%
269,752
-11.1%
0.00%
-33.3%
Q3 2012$8,189,000
-3.2%
303,422
-10.9%
0.01%
-14.3%
Q2 2012$8,460,000340,4590.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Camber Capital Management LP 6,635,000$106,4253.51%
Glenview Capital Management 3,783,982$60,695,0711.37%
AMH Equity Ltd 47,285$758,4510.83%
DISCIPLINED GROWTH INVESTORS INC /MN 1,973,312$31,651,9240.75%
EARNEST PARTNERS LLC 3,473,281$55,711,4270.32%
AIMZ Investment Advisors, LLC 40,985$657,3990.29%
PEREGRINE CAPITAL MANAGEMENT LLC 280,767$4,503,5030.13%
Beverly Hills Private Wealth, LLC 19,687$315,7790.09%
Artisan Partners Limited Partnership 2,537,147$40,695,8380.07%
Jump Financial, LLC 84,924$1,362,1810.05%
View complete list of MYRIAD GENETICS INC shareholders